P&G Q3 core EPS rises 3% to $1.59; FY 2026 guidance maintained
Procter & Gamble reported third-quarter fiscal 2026 results with organic sales up 3% and core earnings per share up 3% to $1.59, while currency-neutral core EPS was flat at $1.54. The company maintained its fiscal 2026 guidance, including core EPS growth of 0% to 4%, though core operating margin fell 80 basis points to 22.2%.
Key points
- Organic sales grew 3%, with volume up 2% and pricing up 1%; diluted EPS was $1.63 versus $1.54 a year earlier.
- Core gross margin was 50.0%, down 100 basis points, and core operating margin was 22.2%, down 80 basis points.
- FY 2026 guidance was maintained: organic sales growth of 0% to 4%, core EPS growth of 0% to 4%, and all-in EPS growth of 1% to 6%.
- Clorox bought P&G's minority interest in the Glad joint venture for $476 million, producing an after-tax gain of $261 million that was excluded from core EPS.
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.